These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15146899)

  • 1. Hemorrhagic complications of anticoagulant therapy in Chinese patients.
    Chan TY; Miu KY
    J Chin Med Assoc; 2004 Feb; 67(2):55-62. PubMed ID: 15146899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Musolesi S
    Lancet; 1996 Aug; 348(9025):423-8. PubMed ID: 8709780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E serum levels and bleeding risk in patients receiving oral anticoagulant therapy: a retrospective cohort study.
    Pastori D; Carnevale R; Cangemi R; Saliola M; Nocella C; Bartimoccia S; Vicario T; Farcomeni A; Violi F; Pignatelli P
    J Am Heart Assoc; 2013 Oct; 2(6):e000364. PubMed ID: 24166490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with warfarin in Chinese population.
    Chenhsu RY; Chiang SC; Chou MH; Lin MF
    Ann Pharmacother; 2000 Dec; 34(12):1395-401. PubMed ID: 11144695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Larsen TB; Skjøth F; Nielsen PB; Kjældgaard JN; Lip GY
    BMJ; 2016 Jun; 353():i3189. PubMed ID: 27312796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation.
    Suzuki S; Yamashita T; Kato T; Fujino T; Sagara K; Sawada H; Aizawa T; Fu LT
    Circ J; 2007 May; 71(5):761-5. PubMed ID: 17457005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    Calkins H; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Serota H; Nordaby M; Guiver K; Biss B; Brouwer MA; Grimaldi M;
    N Engl J Med; 2017 Apr; 376(17):1627-1636. PubMed ID: 28317415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
    Noseworthy PA; Yao X; Gersh BJ; Hargraves I; Shah ND; Montori VM
    Int J Cardiol; 2017 Oct; 245():174-177. PubMed ID: 28733071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.
    Wu S; Xie S; Xu Y; Que D; Yau TO; Wang L; Huang Y
    J Clin Nurs; 2019 May; 28(9-10):1839-1846. PubMed ID: 30667111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
    Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulants usage in Japanese patients aged 18-74 years with non-valvular atrial fibrillation: a retrospective analysis based on insurance claims data.
    Ohshima A; Koyama T; Ogawa A; Zamami Y; Tanaka HY; Kitamura Y; Sendo T; Hinotsu S; Miller MW; Kano MR
    Fam Pract; 2019 Nov; 36(6):685-692. PubMed ID: 31329899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical heart valves: a tertiary hospital-based study in Botswana.
    Botsile E; Mwita JC
    Cardiovasc J Afr; 2020; 31(4):185-189. PubMed ID: 32181794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berretini M; Musolesi S
    G Ital Cardiol; 1997 Mar; 27(3):231-43. PubMed ID: 9244725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of major bleeding and thromboembolism in Asian patients with nonvalvular atrial fibrillation using direct oral anticoagulants versus warfarin.
    Huang YL; Chen CY; Chu CC
    Int J Clin Pharm; 2022 Feb; 44(1):34-43. PubMed ID: 34324128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
    Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
    Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
    Yasaka M; Minematsu K; Yamaguchi T
    Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
    Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
    Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.